A chronological examination of the CB5005 record, from its patent sequence and early cell experiments to later peer-reviewed studies in cells, spheroids, and mice.
A chronological, evidence-led examination of CB5005, from its dual-function sequence and foundational patent to later glioma and lung-cancer delivery studies.
An evidence-led timeline of Celtek Bioscience, covering its reported 2002 formation, early NIH Phase I awards, apoptosis-related patent work, and later preclinical delivery research.